Publications by authors named "Peter Lang"

Transfusion-dependent β-thalassemia (TDT) can have negative impacts on a patient's health-related quality of life (HRQoL). Exagamglogene autotemcel (exa-cel) is a one-time, ex vivo CRISPR-Cas9 gene-edited cell therapy for TDT shown in a Phase 3 clinical trial to result in transfusion independence in most participants. Here, we describe changes in patient-reported outcome (PRO) measures following exa-cel infusion in 54 participants (n=35 adults; n=19 adolescents) who had ≥16 months of follow-up.

View Article and Find Full Text PDF

Identification of previous SARS-CoV-2 infection typically relies on serology, yet T-cells play a key role in the adaptive immune response against SARS-CoV-2. Here, we investigated in parallel the SARS-CoV-2-specific as well as endemic human coronavirus-specific humoral and cross-reactive cellular responses in children and adults. We analyzed clinical data and blood samples from a family cohort of 96 children and 144 adults at 3-4 and 11-12 months after their first contact with SARS-CoV-2.

View Article and Find Full Text PDF

Introduction: Data sharing is critical for improving patient outcomes and ensuring research transparency. However, adherence to the International Committee of Medical Journal Editors guidelines requiring data-sharing statements (DSS) in clinical trials remains inconsistent within surgical research.

Methods: A systematic review and cross-sectional analysis of 1094 articles from the top h-5 indexed surgery journals (2020-2023) was conducted.

View Article and Find Full Text PDF

The clinical course of neuroblastoma is more heterogeneous than any other malignant disease. Many low-risk patients experience regression after limited or even no chemotherapy. However, more than half of high-risk patients die from disease despite intensive multimodal treatment.

View Article and Find Full Text PDF

Targeted next generation sequencing-based HLA typing of a 17-year-old female transplant patient showed homozygosity for the HLA-B allele. The segregation analysis of HLA haplotypes of family members only allowed the conclusion that the B-allele was deleted in the haplotype inherited from the father and accordingly paternal grandfather, resulting in false homozygous genotyping. The subsequent whole-genome sequencing of the patient and her father confirmed an approximately 85 kb deletion at 6p21.

View Article and Find Full Text PDF

Background: Severe combined immunodeficiency (SCID) and severe hemophilia A are 2 rare and potentially life-threatening congenital diseases. The coincidence of these diseases has not been reported so far.

Key Clinical Question: We present the first case of a newborn with both diseases.

View Article and Find Full Text PDF

Reductions in both the size of the amygdala and functional activity during emotional processing have been independently associated with trauma exposure and severity, raising the question of whether reduced volume prompts reduced functional activation. In this multimodal assessment, the relationship between amygdala structure and function was investigated in mood and anxiety patients to determine their covariation and their relationship to trauma magnitude. Overall, amygdala volume and functional emotional reactivity were unrelated, with smaller volumes and reduced emotional reactivity each independently predicting trauma magnitude for women, and mediation analysis did not support a hypothesis that the relationship between reduced functional activity and trauma severity depends on amygdala volume.

View Article and Find Full Text PDF

Exocrine pancreatic insufficiency (EPI) is suspected but remains understudied in immunosuppressed conditions such as post-hematopoietic stem cell transplantation (HSCT). This prospective observational study aimed to investigate the incidence, impact, and risk factors of EPI in a cohort of 83 pediatric and young adult patients who underwent allogeneic HSCT at Charité - Universitätsmedizin Berlin between 2020 and 2023. Fecal pancreatic elastase (PE) measurements and transabdominal ultrasound were utilized to evaluate pancreatic function over a one-year period.

View Article and Find Full Text PDF

Anti-CD19 chimeric antigen receptor T cells (CAR) are a well-established treatment option for children and young adults suffering from relapsed/refractory B-lineage acute lymphoblastic leukemia. Bridging therapy is used to control disease prior to start of lymphodepletion before CAR infusion and thereby improve efficacy of CAR therapy. However, the effect of different bridging strategies on outcome, side effects and response to CAR therapy is still poorly understood.

View Article and Find Full Text PDF

Background: The incorporation of anti-GD2 antibodies such as ch14.18/SP2/0 into the multimodal treatment of high-risk neuroblastoma (HR-NB) patients has improved their outcomes. As studies assessing the long-term outcomes, long-term sequelae, and health-related quality of life (HRQoL) of this treatment are limited, this retrospective analysis aimed to explore these.

View Article and Find Full Text PDF

Hematopoietic stem cell transplantation (HSCT) serves as a therapeutic intervention for various pediatric diseases. Acute and chronic graft-versus-host disease (GVHD) are decisive determinants of successful allogeneic HSCT. The immunosuppressive agent cyclosporin A (CsA) is most often used to prevent GVHD in pediatric patients, but it is known to be nephrotoxic.

View Article and Find Full Text PDF
Article Synopsis
  • * An analysis of 1,192 participants revealed elevated sACE2 activity following exposure to SARS-CoV-2, especially in children, indicating a significant response regardless of infection status.
  • * The research suggests that increased sACE2 activity could help manage SARS-CoV-2 infections, proposing a more nuanced understanding of immune responses beyond traditional infection classifications.
View Article and Find Full Text PDF

Three-dimensional (3D) imaging of cleared intact brains of animal models and large human and non-human primate postmortem brain specimens is important for understanding the physiological neural network connectivity patterns and the pathological alterations underlying neuropsychiatric and neurological disorders. Light-sheet microscopy has emerged as a highly effective imaging modality for rapid high-resolution imaging of large cleared samples. However, the orthogonal arrangements of illumination and detection optics in light sheet microscopy limits the size of specimen that can be imaged.

View Article and Find Full Text PDF
Article Synopsis
  • Targeting acute myeloid leukemia (AML) with CAR-T cells is complex due to the widespread expression of AML antigens in healthy cells and the variability between different patients and even within the same patient's tumor cells.
  • Single-cell analysis of 30 pediatric AML samples highlighted CD33, CD38, CD371, IL1RAP, and CD123 as key antigens, underscoring the need for multiple targeting strategies.
  • The study introduces a modular Adapter CAR platform that allows for flexible and effective targeting of these antigens, showing that combining targets can lead to better treatment outcomes in heterogeneous AML populations.
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the short-term outcomes of surgical aortic valve replacement (SAVR) in elderly patients aged 70 and above, comparing those aged 70-79 years with those aged 80 and older.
  • Both age groups showed similar survival rates at 30 days and 1 year post-SAVR, indicating that age alone does not predict poorer outcomes.
  • Risk factors for higher mortality included insulin-dependent diabetes and severe heart failure (NYHA class IV), which should be carefully considered when selecting elderly patients for SAVR.
View Article and Find Full Text PDF

Background: Neuroblastoma is the most common extracranial solid tumour in children. Relapsed or refractory neuroblastoma is associated with a poor outcome. We assessed the combination of irinotecan-temozolomide and dasatinib-rapamycin (RIST) in patients with relapsed or refractory neuroblastoma.

View Article and Find Full Text PDF

Background And Aims: High-dose chemotherapy (HDC) followed by autologous stem cell transplantation (ASCT) improves the prognosis in pediatric patients with several solid tumors and lymphomas. Little is known about the reconstitution of the immune system after ASCT and the influence of CD34+ cell selection on the reconstitution in pediatric patients.

Methods: Between 1990 and 2001, 94 pediatric patients with solid tumors and lymphomas received autologous CD34+ selected or unmanipulated peripheral stem cells after HDC.

View Article and Find Full Text PDF

Background: Reactivation of viral infections, in particular cytomegalovirus (CMV) and adenovirus (ADV), cause morbidity and non-relapse-mortality in states of immune deficiency, especially after allogeneic hematopoietic cell transplantation (allo-HCT). Against the background of few available pharmacologic antiviral agents, limited by toxicities and resistance, adoptive transfer of virus-specific T-cells (VST) is a promising therapeutic approach.

Methods: We conducted a single-center retrospective analysis of adult patients treated with ADV- or CMV-specific T-cells in 2012-2022.

View Article and Find Full Text PDF
Article Synopsis
  • Cell- and antibody-based therapies targeting CD19 show promise for treating B-cell non-Hodgkin lymphoma (B-NHL), but challenges like low response rates and toxicity remain.
  • Researchers developed a noninvasive imaging technique called CD19-immunoPET using radiolabeled antibodies to accurately visualize CD19 expression in lymphoma patients, revealing variations in expression levels.
  • The findings suggest that CD19-immunoPET could help tailor CD19-targeted treatments by identifying the diversity of CD19 expression in different lymphoma lesions, enhancing treatment personalization.
View Article and Find Full Text PDF
Article Synopsis
  • Exagamglogene autotemcel (exa-cel) is a novel cell therapy using CRISPR-Cas9 gene editing to boost fetal hemoglobin production in patients with transfusion-dependent β-thalassemia.
  • In a phase 3 study, 52 patients aged 12 to 35 underwent treatment with exa-cel after myeloablative conditioning, and 91% achieved transfusion independence for at least 12 months.
  • The therapy showed promising results with high mean total and fetal hemoglobin levels, a favorable safety profile, and no serious adverse events like deaths or cancers reported during the follow-up period.
View Article and Find Full Text PDF
Article Synopsis
  • * Treatment options varied; two patients received intravenous immunoglobulins, with one recovering slowly and the other needing a stem cell transplant, while two others were treated with immunosuppressive therapy.
  • * Despite the challenges, all patients are currently alive, highlighting that VZV-related BMF is a serious condition that may necessitate stem cell transplantation for recovery.
View Article and Find Full Text PDF